(1S,3AS,3BR,10AR,10BS,13S,13AS,15AS,18BS,20AS)-13A,17,17,20A-TETRAMETHYL-2,3,3A,3B,4,5,9,10,10A,10B,11,12,13,13A,14,15,15A,17,18B,19,20,20A-DOCOSAHYDRO-1H-BIS(CYCLOPENTA(5,6)NAPHTHO)(1,2-B:2',1'-I)XANTHENE-1,13-DIYL DIPENTANOATE
UNII VAU7W8E4C4

Substance Identification & Data

This profile provides standardized clinical and technical data for (1s,3as,3br,10ar,10bs,13s,13as,15as,18bs,20as)-13a,17,17,20a-tetramethyl-2,3,3a,3b,4,5,9,10,10a,10b,11,12,13,13a,14,15,15a,17,18b,19,20,20a-docosahydro-1h-bis(cyclopenta(5,6)naphtho)(1,2-b:2',1'-i)xanthene-1,13-diyl Dipentanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VAU7W8E4C4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VAU7W8E4C4

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

(1S,3AS,3BR,10AR,10BS,13S,13AS,15AS,18BS,20AS)-13A,17,17,20A-TETRAMETHYL-2,3,3A,3B,4,5,9,10,10A,10B,11,12,13,13A,14,15,15A,17,18B,19,20,20A-DOCOSAHYDRO-1H-BIS(CYCLOPENTA(5,6)NAPHTHO)(1,2-B:2',1'-I)XANTHENE-1,13-DIYL DIPENTANOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C49H66O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GJTZBYWHNGBUPT-FMJXVDBGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

176487519

Unique identification number in the NCBI database of chemical substances.

Substance Type

(1S,3aS,3bR,10aR,10bS,13S,13aS,15aS,18bS,20aS)-13a,17,17,20a-tetramethyl-2,3,3a,3b,4,5,9,10,10a,10b,11,12,13,13a,14,15,15a,17,18b,19,20,20a-docosahydro-1H-bis(cyclopenta[5,6]naphtho)[1,2-b:2?,1?-i]xanthene-1,13-diyl dipentanoate

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CCCCC(=O)O[C@@]1([H])CC[C@@]2([H])[C@]3([H])CCc4cc5c(cc4[C@@]3([H])CC[C@@]21C)C(C)(C)c6cc7c(CC[C@]8([H])[C@@]7(CC[C@@]9(C)[C@@]8([H])CC[C@]9([H])OC(=O)CCCC)[H])cc6O5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for (1s,3as,3br,10ar,10bs,13s,13as,15as,18bs,20as)-13a,17,17,20a-tetramethyl-2,3,3a,3b,4,5,9,10,10a,10b,11,12,13,13a,14,15,15a,17,18b,19,20,20a-docosahydro-1h-bis(cyclopenta(5,6)naphtho)(1,2-b:2',1'-i)xanthene-1,13-diyl Dipentanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

Estradiol valerate Impurity I [EP IMPURITY]

Systematic Nomenclature

SYS

External Clinical & Regulatory Resources

Previous UNIIVAU3JK4C3O

Next UNIIVAV397C9AE